Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13462239 | 1.00 | CHRNB4 (0.45) | CHRNB4CHRNA3 | |
| SCHEMBL5995159 | 0.82 | CHRNB4 (0.46) | CHRNB4CHRNA3 | |
| SCHEMBL10285822 | 0.82 | CHRNB4 (0.46) | CHRNB4CHRNA3 | |
| SCHEMBL13850465 | 0.82 | CHRNB4 (0.46) | CHRNB4CHRNA3 | |
| SCHEMBL2459458 | 0.79 | CHRNB4 (0.50) | CHRNB4CHRNA3 | |
| SCHEMBL254110 | 0.77 | — | — | |
| SCHEMBL96320 | 0.77 | — | — | |
| SCHEMBL88569 | 0.77 | — | — | |
| SCHEMBL25962289 | 0.76 | CYP1A2 (0.48) | CHRNB4CHRNA3 | |
| SCHEMBL15806843 | 0.76 | CYP1A2 (0.48) | CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046317-A1 | NOVEL HETEROCYCLIC COMPOUNDS | DUTT CHAITANYA (IN) | 2012-02-23 | — | — | US | disclosed |
| WO-2010128528-A2 | NOVEL HETEROCYCLIC COMPOUNDS | TORRENT PHARMACEUTICALS LIMITED (IN) | 2010-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046317-A1 | NOVEL HETEROCYCLIC COMPOUNDS | AGER, REN, AGT | CHRNB4 3101/4885CHRNA3 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.